| Revenue growth | ₹83.46 Cr H1, +71.59% YoY; project-execution driven. |
|---|---|
| Margins | EBITDA margin 12.29% vs 11.7% prior H1, below FY26's 13.7%. |
| Order book | Value not stated; about 60% to execute in FY27, rest next year. |
| Demand visibility | Govt pipeline strong; ₹30 Cr smart parking, repeat NHAI orders expected. |
| Management confidence | Over-optimistic; confident claims, few numbers on margins and defence. |
Growth
Revenue +71.59%, EBITDA +80.02%, PAT +126.29%; EBITDA margin 12.29% vs 11.7%. Profit growth outpaces sales.
Outlook
The ₹170 Cr FY27 target implies about ₹86.5 Cr in H2. No growth % was guided. LMS first orders expected next quarter.
Risks
EBITDA margin 12.29% is still below FY26's 13.7%, with cost pressure and no sustainable range given. Defence order awaits approval; LMS revenue unproven.
Earnings Call Transcript filed with NSE, NSE: MARUSHIKA. Summary written with AI assistance from the document.
Marushika Technology Ltd: key numbers
- Share price
- ₹120.00
- Market cap
- ₹102.4 Cr
- Revenue (annual)
- ₹116.4 Cr
- Net profit (annual)
- ₹8.95 Cr
- P/E (TTM)
- 11.4×Sector 23.8×
- Promoter holding
- 58.19%
- FII holding
- 5.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Marushika Technology Ltd
All →Marushika Technology Investor Presentation: Key Takeaways
H1 FY27 revenue ₹8,346 lakh (+71.6% YoY), PAT ₹704 lakh (+126.3%), EBITDA margin 12.3%. Expansion into defence auto-tech, LMS and healthcare via Sanare partnership.
Marushika Technology Results Update
Marushika reported H1 FY27 revenue growth of 71.59% and net profit growth of 126.30% year-on-year. The release shows highlights only, not a full results statement.
Marushika Technology H1 FY27 Results: Net Profit ₹7 Cr, Up 125.8% YoY
Marushika Technology Ltd reported revenue from operations of ₹83.5 Cr (+71.8% YoY) and net profit of ₹7 Cr (+125.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹7 Cr · +125.8% YoY
Marushika Technology Other Announcement
Marushika Technology filed a Reg 27(2) non-applicability certificate for corporate governance for the half-year ended September 30, 2026. As an NSE Emerge-listed SME, the corporate governance provisions do not apply to it.
Marushika Technology Annual General Meeting
Marushika Technology Limited held its 16th Annual General Meeting on September 25, 2026. The meeting covered the adoption of financial statements and various board appointments.
Marushika Technology Partnership
Marushika Technology commenced a partnership with Sanare Medical as exclusive distributor of ExoAtlet II. The agreement targets government procurement via GeM across Indian public institutions.